COMPOSITION:
Each film-coated tablet contains Valganciclovir HCl 496.3 mg equivalent to Valganciclovir……… 450mg.
INDICATION:
LuciValgan is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for:
Adult Patients:
• Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS).
• Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk.
Pediatric Patients:
• Prevention of CMV disease in kidney and heart transplant patients at high risk.
DOSAGE AND USE:
See full prescribing information for LuciValgan.
STORAGE:
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY:
LUCIUS PHARMACEUTICALS(LAO) CO., LTD
No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING:
Keep medicine out of reach of Children. Do not administer LuciValgan during Pregnancy and Lactation.
Customer Reviews
Write a review
Cobus Bester
Cobus Bester on Mar 03, 2023
Can’t wait to start mixin’ with this one! Irba-irr-Up-up-up-up-date your theme!
Report as Inappropriate